A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
- Conditions
- Alopecia AreataPsoriasisChronic Spontaneous UrticariaAtopic DermatitisHidradenitis SuppurativaVitiligo
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Target Recruit Count
- 15000
- Registration Number
- NCT03661866
- Locations
- ๐บ๐ธ
Clear Dermatology & Aesthetics Center/Investigative MD, Scottsdale, Arizona, United States
๐บ๐ธJohnson Dermatology, Fort Smith, Arkansas, United States
๐บ๐ธUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
- Conditions
- Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative ColitisIndeterminate Colitis
- First Posted Date
- 2017-08-16
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Target Recruit Count
- 15000
- Registration Number
- NCT03251118
- Locations
- ๐บ๐ธ
Om Research, Lancaster, California, United States
๐บ๐ธFACEY Medical Foundation, Mission Hills, California, United States
๐บ๐ธUniversity of California - Davis, Sacramento, California, United States
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
- Conditions
- Hepatocellular Cancer
- First Posted Date
- 2016-11-03
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Target Recruit Count
- 10000
- Registration Number
- NCT02954094
- Locations
- ๐บ๐ธ
Baylor Scott & White All Saints, Fort Worth, Texas, United States
๐บ๐ธResearch Specialists of Texas, Houston, Texas, United States
๐บ๐ธUniversity of Arkansas, Little Rock, Arkansas, United States
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
- Conditions
- Biliary Cirrhosis, Primary
- First Posted Date
- 2016-10-13
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT02932449
- Locations
- ๐บ๐ธ
Southern Therapy and Advanced Research LLC (STAR), Jackson, Mississippi, United States
๐บ๐ธSandra Atlas Bass Center for Liver Diseases, Manhasset, New York, United States
๐บ๐ธSCFLD/University of Miami, Miami, Florida, United States
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
- Conditions
- Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
- First Posted Date
- 2016-06-28
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Target Recruit Count
- 15000
- Registration Number
- NCT02815891
- Locations
- ๐บ๐ธ
Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic, Phoenix, Arizona, United States
๐บ๐ธStanford University, Palo Alto, California, United States
๐บ๐ธCalifornia Liver Research Institute, Pasadena, California, United States